nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—appendage—muscle cancer	0.124	0.413	CbGeAlD
Pentosan Polysulfate—FGF4—embryo—muscle cancer	0.0413	0.137	CbGeAlD
Pentosan Polysulfate—FGF1—appendage—muscle cancer	0.0328	0.109	CbGeAlD
Pentosan Polysulfate—FGF4—head—muscle cancer	0.0209	0.0695	CbGeAlD
Pentosan Polysulfate—FGF2—smooth muscle tissue—muscle cancer	0.0115	0.0383	CbGeAlD
Pentosan Polysulfate—FGF1—embryo—muscle cancer	0.0109	0.0363	CbGeAlD
Pentosan Polysulfate—FGF2—tendon—muscle cancer	0.00866	0.0288	CbGeAlD
Pentosan Polysulfate—FGF1—smooth muscle tissue—muscle cancer	0.00858	0.0285	CbGeAlD
Pentosan Polysulfate—FGF1—renal system—muscle cancer	0.00826	0.0275	CbGeAlD
Pentosan Polysulfate—FGF2—vagina—muscle cancer	0.00804	0.0267	CbGeAlD
Pentosan Polysulfate—FGF1—cardiac atrium—muscle cancer	0.00739	0.0246	CbGeAlD
Pentosan Polysulfate—FGF2—testis—muscle cancer	0.00717	0.0239	CbGeAlD
Pentosan Polysulfate—Raised liver function tests—Dactinomycin—muscle cancer	0.00619	0.0343	CcSEcCtD
Pentosan Polysulfate—FGF1—head—muscle cancer	0.00552	0.0184	CbGeAlD
Pentosan Polysulfate—FGF1—testis—muscle cancer	0.00534	0.0177	CbGeAlD
Pentosan Polysulfate—Nystagmus—Vincristine—muscle cancer	0.00357	0.0198	CcSEcCtD
Pentosan Polysulfate—Menorrhagia—Vincristine—muscle cancer	0.00345	0.0191	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Etoposide—muscle cancer	0.00336	0.0186	CcSEcCtD
Pentosan Polysulfate—Raised liver function tests—Methotrexate—muscle cancer	0.00268	0.0149	CcSEcCtD
Pentosan Polysulfate—Prothrombin level increased—Doxorubicin—muscle cancer	0.00261	0.0145	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Dactinomycin—muscle cancer	0.00261	0.0145	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Dactinomycin—muscle cancer	0.00258	0.0143	CcSEcCtD
Pentosan Polysulfate—Appetite absent—Methotrexate—muscle cancer	0.00249	0.0138	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Vincristine—muscle cancer	0.00231	0.0128	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Dactinomycin—muscle cancer	0.00192	0.0106	CcSEcCtD
Pentosan Polysulfate—Gingival bleeding—Doxorubicin—muscle cancer	0.00189	0.0105	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Etoposide—muscle cancer	0.00189	0.0105	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Etoposide—muscle cancer	0.00187	0.0104	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Doxorubicin—muscle cancer	0.00182	0.0101	CcSEcCtD
Pentosan Polysulfate—Pelvic pain—Doxorubicin—muscle cancer	0.00176	0.00977	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Doxorubicin—muscle cancer	0.00174	0.00966	CcSEcCtD
Pentosan Polysulfate—Dehydration—Vincristine—muscle cancer	0.00172	0.00955	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Dactinomycin—muscle cancer	0.00156	0.00863	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Doxorubicin—muscle cancer	0.0015	0.00832	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Vincristine—muscle cancer	0.00146	0.0081	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Vincristine—muscle cancer	0.00145	0.00803	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Dactinomycin—muscle cancer	0.00142	0.00789	CcSEcCtD
Pentosan Polysulfate—Depression—Vincristine—muscle cancer	0.00142	0.00789	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Vincristine—muscle cancer	0.00139	0.00771	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Doxorubicin—muscle cancer	0.00139	0.0077	CcSEcCtD
Pentosan Polysulfate—Sweating—Vincristine—muscle cancer	0.00137	0.00759	CcSEcCtD
Pentosan Polysulfate—Alopecia—Dactinomycin—muscle cancer	0.00127	0.00702	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Etoposide—muscle cancer	0.00126	0.007	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Methotrexate—muscle cancer	0.00124	0.00686	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD34—muscle cancer	0.00123	0.00236	CbGpPWpGaD
Pentosan Polysulfate—Amenorrhoea—Doxorubicin—muscle cancer	0.00122	0.00676	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.00122	0.00234	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—muscle cancer	0.00121	0.00233	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—FOXO1—muscle cancer	0.0012	0.00232	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—FOXO4—muscle cancer	0.0012	0.00231	CbGpPWpGaD
Pentosan Polysulfate—Rectal haemorrhage—Doxorubicin—muscle cancer	0.00119	0.00658	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by SCF-KIT—MDM2—muscle cancer	0.00119	0.00229	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—FOXO1—muscle cancer	0.00118	0.00228	CbGpPWpGaD
Pentosan Polysulfate—Vaginal infection—Methotrexate—muscle cancer	0.00117	0.00648	CcSEcCtD
Pentosan Polysulfate—FGF2—PI-3K cascade—KIT—muscle cancer	0.00117	0.00225	CbGpPWpGaD
Pentosan Polysulfate—Lacrimation increased—Doxorubicin—muscle cancer	0.00116	0.00645	CcSEcCtD
Pentosan Polysulfate—FGF4—B Cell Activation—KIT—muscle cancer	0.00116	0.00224	CbGpPWpGaD
Pentosan Polysulfate—Ill-defined disorder—Dactinomycin—muscle cancer	0.00116	0.00642	CcSEcCtD
Pentosan Polysulfate—Anaemia—Dactinomycin—muscle cancer	0.00115	0.0064	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—FOXO1—muscle cancer	0.00114	0.00221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.00114	0.00221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI3K/AKT activation—KIT—muscle cancer	0.00114	0.0022	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.00114	0.00219	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Vincristine—muscle cancer	0.00113	0.00628	CcSEcCtD
Pentosan Polysulfate—FGF2—GAB1 signalosome—KIT—muscle cancer	0.00113	0.00218	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—FOXO1—muscle cancer	0.00113	0.00218	CbGpPWpGaD
Pentosan Polysulfate—Stomatitis—Etoposide—muscle cancer	0.00113	0.00625	CcSEcCtD
Pentosan Polysulfate—Jaundice—Etoposide—muscle cancer	0.00113	0.00625	CcSEcCtD
Pentosan Polysulfate—Malaise—Dactinomycin—muscle cancer	0.00113	0.00624	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR—FOXO1—muscle cancer	0.00112	0.00217	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—FOXO1—muscle cancer	0.00112	0.00217	CbGpPWpGaD
Pentosan Polysulfate—Ecchymosis—Methotrexate—muscle cancer	0.00112	0.0062	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Methotrexate—muscle cancer	0.00112	0.0062	CcSEcCtD
Pentosan Polysulfate—FGF1—Constitutive PI3K/AKT Signaling in Cancer—MDM2—muscle cancer	0.00112	0.00216	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Dactinomycin—muscle cancer	0.00112	0.00619	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—FOXO1—muscle cancer	0.00112	0.00216	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB4—MDM2—muscle cancer	0.00112	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.00111	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—FOXO1—muscle cancer	0.00111	0.00214	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—muscle cancer	0.0011	0.00213	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.0011	0.00211	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—FOXO1—muscle cancer	0.0011	0.00211	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—FOXO1—muscle cancer	0.00108	0.00208	CbGpPWpGaD
Pentosan Polysulfate—Vaginal inflammation—Doxorubicin—muscle cancer	0.00107	0.00594	CcSEcCtD
Pentosan Polysulfate—FGF4—Downstream signal transduction—MDM2—muscle cancer	0.00107	0.00206	CbGpPWpGaD
Pentosan Polysulfate—Myalgia—Dactinomycin—muscle cancer	0.00106	0.00589	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by FGFR—MDM2—muscle cancer	0.00106	0.00205	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—MDM2—muscle cancer	0.00106	0.00204	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 signaling—MDM2—muscle cancer	0.00105	0.00203	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Dactinomycin—muscle cancer	0.00105	0.00582	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—FOXO1—muscle cancer	0.00105	0.00202	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—FOXO1—muscle cancer	0.00105	0.00202	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.00105	0.00202	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—FOXO1—muscle cancer	0.00104	0.002	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.00104	0.002	CbGpPWpGaD
Pentosan Polysulfate—Anaemia—Vincristine—muscle cancer	0.00103	0.00571	CcSEcCtD
Pentosan Polysulfate—Colitis—Doxorubicin—muscle cancer	0.00103	0.00571	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signal transduction—FOXO1—muscle cancer	0.00103	0.00198	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—FOXO1—muscle cancer	0.00103	0.00198	CbGpPWpGaD
Pentosan Polysulfate—Agitation—Vincristine—muscle cancer	0.00103	0.00568	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by FGFR—FOXO1—muscle cancer	0.00102	0.00197	CbGpPWpGaD
Pentosan Polysulfate—Photosensitivity—Methotrexate—muscle cancer	0.00102	0.00567	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by PDGF—FOXO1—muscle cancer	0.00102	0.00197	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—MDM2—muscle cancer	0.00102	0.00197	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Dactinomycin—muscle cancer	0.00102	0.00565	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—FOXO1—muscle cancer	0.00102	0.00197	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—FOXO1—muscle cancer	0.00101	0.00196	CbGpPWpGaD
Pentosan Polysulfate—Infection—Dactinomycin—muscle cancer	0.00101	0.00561	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Doxorubicin—muscle cancer	0.00101	0.00561	CcSEcCtD
Pentosan Polysulfate—FGF1—PI-3K cascade—MDM2—muscle cancer	0.00101	0.00194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.001	0.00193	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Vincristine—muscle cancer	0.000999	0.00553	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Dactinomycin—muscle cancer	0.000998	0.00553	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrins in angiogenesis—VEGFA—muscle cancer	0.000994	0.00192	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—MDM2—muscle cancer	0.000989	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000989	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—MDM2—muscle cancer	0.000989	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI3K/AKT activation—MDM2—muscle cancer	0.000984	0.0019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Endochondral Ossification—VEGFA—muscle cancer	0.000981	0.00189	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—MDM2—muscle cancer	0.000981	0.00189	CbGpPWpGaD
Pentosan Polysulfate—Oesophagitis—Doxorubicin—muscle cancer	0.00098	0.00543	CcSEcCtD
Pentosan Polysulfate—FGF1—GAB1 signalosome—MDM2—muscle cancer	0.000976	0.00188	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000972	0.00187	CbGpPWpGaD
Pentosan Polysulfate—Anorexia—Dactinomycin—muscle cancer	0.000972	0.00538	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Doxorubicin—muscle cancer	0.00097	0.00537	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Doxorubicin—muscle cancer	0.00097	0.00537	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—FOXO1—muscle cancer	0.000969	0.00187	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—MDM2—muscle cancer	0.000968	0.00187	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—FOXO4—muscle cancer	0.000965	0.00186	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KIDINS220—muscle cancer	0.000965	0.00186	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—KIT—muscle cancer	0.000957	0.00184	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—FOXO1—muscle cancer	0.000954	0.00184	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—FOXO1—muscle cancer	0.000954	0.00184	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.000954	0.00184	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—MDM2—muscle cancer	0.000954	0.00184	CbGpPWpGaD
Pentosan Polysulfate—Myalgia—Vincristine—muscle cancer	0.00095	0.00526	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR—FOXO1—muscle cancer	0.000946	0.00182	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—FOXO1—muscle cancer	0.000938	0.00181	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—FOXO1—muscle cancer	0.000933	0.0018	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000929	0.00515	CcSEcCtD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.000927	0.00179	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI-3K cascade—MDM2—muscle cancer	0.000919	0.00177	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Etoposide—muscle cancer	0.000918	0.00508	CcSEcCtD
Pentosan Polysulfate—FGF4—B Cell Activation—MDM2—muscle cancer	0.000916	0.00177	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—KIT—muscle cancer	0.000915	0.00176	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Vincristine—muscle cancer	0.000911	0.00505	CcSEcCtD
Pentosan Polysulfate—Infection—Vincristine—muscle cancer	0.000905	0.00501	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—KIT—muscle cancer	0.000901	0.00174	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI3K/AKT activation—MDM2—muscle cancer	0.000897	0.00173	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Vincristine—muscle cancer	0.000892	0.00494	CcSEcCtD
Pentosan Polysulfate—FGF2—GAB1 signalosome—MDM2—muscle cancer	0.00089	0.00172	CbGpPWpGaD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—muscle cancer	0.000887	0.00491	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dactinomycin—muscle cancer	0.000886	0.00491	CcSEcCtD
Pentosan Polysulfate—FGF2—B Cell Activation—FOXO1—muscle cancer	0.000883	0.0017	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Vincristine—muscle cancer	0.000881	0.00488	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—FOXO4—muscle cancer	0.00088	0.0017	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000876	0.00169	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—KIT—muscle cancer	0.000872	0.00168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—MDM2—muscle cancer	0.00087	0.00168	CbGpPWpGaD
Pentosan Polysulfate—Anorexia—Vincristine—muscle cancer	0.000868	0.00481	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—FOXO4—muscle cancer	0.000867	0.00167	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—KIT—muscle cancer	0.00086	0.00166	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—KIT—muscle cancer	0.000856	0.00165	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—KIT—muscle cancer	0.000856	0.00165	CbGpPWpGaD
Pentosan Polysulfate—Mood swings—Methotrexate—muscle cancer	0.000852	0.00472	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—KIT—muscle cancer	0.000852	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—KIT—muscle cancer	0.000848	0.00163	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.000845	0.00163	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Dactinomycin—muscle cancer	0.00084	0.00465	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Etoposide—muscle cancer	0.000839	0.00465	CcSEcCtD
Pentosan Polysulfate—FGF2—Developmental Biology—MYOD1—muscle cancer	0.000836	0.00161	CbGpPWpGaD
Pentosan Polysulfate—Anaemia—Etoposide—muscle cancer	0.000836	0.00463	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	0.000835	0.00161	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—KIT—muscle cancer	0.000835	0.00161	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000834	0.00462	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—FOXO4—muscle cancer	0.000833	0.00161	CbGpPWpGaD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—muscle cancer	0.00083	0.0046	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00083	0.0046	CcSEcCtD
Pentosan Polysulfate—Insomnia—Vincristine—muscle cancer	0.000824	0.00456	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—KIT—muscle cancer	0.000821	0.00158	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Vincristine—muscle cancer	0.000818	0.00453	CcSEcCtD
Pentosan Polysulfate—Malaise—Etoposide—muscle cancer	0.000815	0.00452	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Etoposide—muscle cancer	0.000809	0.00448	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dactinomycin—muscle cancer	0.000806	0.00446	CcSEcCtD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.000797	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—KIT—muscle cancer	0.000797	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—KIT—muscle cancer	0.000797	0.00154	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Vincristine—muscle cancer	0.000792	0.00439	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—KIT—muscle cancer	0.00079	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—KIT—muscle cancer	0.000785	0.00151	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—KIT—muscle cancer	0.000783	0.00151	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—KIT—muscle cancer	0.000781	0.0015	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—KIT—muscle cancer	0.00078	0.0015	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Vincristine—muscle cancer	0.000779	0.00432	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD34—muscle cancer	0.000778	0.0015	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—KIT—muscle cancer	0.000777	0.0015	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—KIT—muscle cancer	0.000773	0.00149	CbGpPWpGaD
Pentosan Polysulfate—Affect lability—Doxorubicin—muscle cancer	0.000766	0.00425	CcSEcCtD
Pentosan Polysulfate—FGF2—Developmental Biology—MED12—muscle cancer	0.000765	0.00147	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	0.000762	0.00147	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Etoposide—muscle cancer	0.00076	0.00421	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—MDM2—muscle cancer	0.000753	0.00145	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Dactinomycin—muscle cancer	0.000751	0.00416	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—muscle cancer	0.000745	0.00413	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vincristine—muscle cancer	0.000745	0.00413	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CD34—muscle cancer	0.000743	0.00143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—KIT—muscle cancer	0.000738	0.00142	CbGpPWpGaD
Pentosan Polysulfate—Mood swings—Doxorubicin—muscle cancer	0.000738	0.00409	CcSEcCtD
Pentosan Polysulfate—Infection—Etoposide—muscle cancer	0.000733	0.00406	CcSEcCtD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.000727	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—KIT—muscle cancer	0.000727	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—KIT—muscle cancer	0.000727	0.0014	CbGpPWpGaD
Pentosan Polysulfate—Dehydration—Doxorubicin—muscle cancer	0.000724	0.00401	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Etoposide—muscle cancer	0.000722	0.004	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000721	0.00139	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—KIT—muscle cancer	0.000721	0.00139	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Vincristine—muscle cancer	0.00072	0.00399	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—muscle cancer	0.000719	0.00398	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—KIT—muscle cancer	0.000714	0.00138	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Etoposide—muscle cancer	0.000713	0.00395	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—FOXO1—muscle cancer	0.000713	0.00137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—KIT—muscle cancer	0.000711	0.00137	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—MDM2—muscle cancer	0.000709	0.00137	CbGpPWpGaD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—muscle cancer	0.000709	0.00393	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD34—muscle cancer	0.000709	0.00137	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000706	0.00136	CbGpPWpGaD
Pentosan Polysulfate—Anorexia—Etoposide—muscle cancer	0.000703	0.0039	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dactinomycin—muscle cancer	0.000698	0.00386	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—muscle cancer	0.000691	0.00383	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—muscle cancer	0.000689	0.00382	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—MDM2—muscle cancer	0.000687	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—MDM2—muscle cancer	0.000678	0.00131	CbGpPWpGaD
Pentosan Polysulfate—Stomatitis—Methotrexate—muscle cancer	0.000675	0.00374	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR—MDM2—muscle cancer	0.000674	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—MDM2—muscle cancer	0.000674	0.0013	CbGpPWpGaD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—muscle cancer	0.000674	0.00373	CcSEcCtD
Pentosan Polysulfate—FGF2—B Cell Activation—KIT—muscle cancer	0.000673	0.0013	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Vincristine—muscle cancer	0.000671	0.00372	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—MDM2—muscle cancer	0.000671	0.00129	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—MDM2—muscle cancer	0.000668	0.00129	CbGpPWpGaD
Pentosan Polysulfate—Sweating—Methotrexate—muscle cancer	0.000664	0.00368	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Etoposide—muscle cancer	0.000663	0.00367	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—muscle cancer	0.000661	0.00366	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.000658	0.00127	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Etoposide—muscle cancer	0.000658	0.00364	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000657	0.00127	CbGpPWpGaD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—muscle cancer	0.000656	0.00363	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—muscle cancer	0.000654	0.00362	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—FOXO1—muscle cancer	0.00065	0.00125	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Dactinomycin—muscle cancer	0.000648	0.00359	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—MDM2—muscle cancer	0.000647	0.00125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000644	0.00124	CbGpPWpGaD
Pentosan Polysulfate—Rash—Dactinomycin—muscle cancer	0.000643	0.00356	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Etoposide—muscle cancer	0.000641	0.00355	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—FOXO1—muscle cancer	0.000641	0.00124	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Etoposide—muscle cancer	0.000631	0.0035	CcSEcCtD
Pentosan Polysulfate—FGF1—DAP12 interactions—MDM2—muscle cancer	0.000628	0.00121	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—MDM2—muscle cancer	0.000628	0.00121	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000628	0.00121	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Vincristine—muscle cancer	0.000623	0.00345	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—MDM2—muscle cancer	0.000622	0.0012	CbGpPWpGaD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—muscle cancer	0.000622	0.00344	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signal transduction—MDM2—muscle cancer	0.000618	0.00119	CbGpPWpGaD
Pentosan Polysulfate—Pharyngitis—Methotrexate—muscle cancer	0.000617	0.00342	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000617	0.00119	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—FOXO1—muscle cancer	0.000615	0.00119	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—MDM2—muscle cancer	0.000615	0.00119	CbGpPWpGaD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000614	0.0034	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by PDGF—MDM2—muscle cancer	0.000614	0.00118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIDINS220—muscle cancer	0.000613	0.00118	CbGpPWpGaD
Pentosan Polysulfate—Weight increased—Doxorubicin—muscle cancer	0.000612	0.00339	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—MDM2—muscle cancer	0.000612	0.00118	CbGpPWpGaD
Pentosan Polysulfate—Weight decreased—Doxorubicin—muscle cancer	0.000609	0.00337	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—MDM2—muscle cancer	0.000609	0.00117	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Etoposide—muscle cancer	0.000608	0.00337	CcSEcCtD
Pentosan Polysulfate—Nausea—Dactinomycin—muscle cancer	0.000606	0.00335	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Etoposide—muscle cancer	0.000603	0.00334	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vincristine—muscle cancer	0.000602	0.00334	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.0006	0.00116	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—TP53—muscle cancer	0.000592	0.00114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000591	0.00114	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Etoposide—muscle cancer	0.000586	0.00325	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—muscle cancer	0.000585	0.00324	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—muscle cancer	0.000585	0.00324	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—muscle cancer	0.000583	0.00323	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—muscle cancer	0.000583	0.00323	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—MDM2—muscle cancer	0.000581	0.00112	CbGpPWpGaD
Pentosan Polysulfate—Tinnitus—Methotrexate—muscle cancer	0.00058	0.00321	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vincristine—muscle cancer	0.000579	0.00321	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—muscle cancer	0.000575	0.00319	CcSEcCtD
Pentosan Polysulfate—Rash—Vincristine—muscle cancer	0.000574	0.00318	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vincristine—muscle cancer	0.000574	0.00318	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 interactions—MDM2—muscle cancer	0.000573	0.0011	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—MDM2—muscle cancer	0.000573	0.0011	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000573	0.0011	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ENO2—muscle cancer	0.000572	0.0011	CbGpPWpGaD
Pentosan Polysulfate—Haematuria—Doxorubicin—muscle cancer	0.000572	0.00317	CcSEcCtD
Pentosan Polysulfate—Headache—Vincristine—muscle cancer	0.000571	0.00316	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.00057	0.0011	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—MDM2—muscle cancer	0.000568	0.00109	CbGpPWpGaD
Pentosan Polysulfate—Epistaxis—Doxorubicin—muscle cancer	0.000566	0.00314	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—muscle cancer	0.000563	0.00312	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000563	0.00108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—MDM2—muscle cancer	0.00056	0.00108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIDINS220—muscle cancer	0.000559	0.00108	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000556	0.00107	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—FOXO4—muscle cancer	0.000551	0.00106	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Methotrexate—muscle cancer	0.00055	0.00305	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Etoposide—muscle cancer	0.000544	0.00301	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—KIT—muscle cancer	0.000543	0.00105	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Vincristine—muscle cancer	0.000541	0.003	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—muscle cancer	0.00054	0.00299	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000539	0.00104	CbGpPWpGaD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—muscle cancer	0.000535	0.00296	CcSEcCtD
Pentosan Polysulfate—FGF2—B Cell Activation—MDM2—muscle cancer	0.00053	0.00102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—FOXO4—muscle cancer	0.000529	0.00102	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Etoposide—muscle cancer	0.000522	0.00289	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—HMGA1—muscle cancer	0.00052	0.001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.00052	0.001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000507	0.000978	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—FOXO4—muscle cancer	0.000505	0.000974	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Etoposide—muscle cancer	0.000505	0.0028	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—muscle cancer	0.000502	0.00278	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—muscle cancer	0.000502	0.00278	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—FOXO4—muscle cancer	0.000502	0.000968	CbGpPWpGaD
Pentosan Polysulfate—Anaemia—Methotrexate—muscle cancer	0.000501	0.00277	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—KIT—muscle cancer	0.000495	0.000955	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Methotrexate—muscle cancer	0.000488	0.00271	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—KIT—muscle cancer	0.000488	0.000941	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Etoposide—muscle cancer	0.000488	0.0027	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—muscle cancer	0.000485	0.00269	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—FOXO4—muscle cancer	0.000482	0.000929	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Doxorubicin—muscle cancer	0.000476	0.00264	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—CD34—muscle cancer	0.000472	0.000909	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Etoposide—muscle cancer	0.000469	0.0026	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KIT—muscle cancer	0.000469	0.000904	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—FOXO4—muscle cancer	0.000466	0.000899	CbGpPWpGaD
Pentosan Polysulfate—Rash—Etoposide—muscle cancer	0.000465	0.00258	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—muscle cancer	0.000465	0.00258	CcSEcCtD
Pentosan Polysulfate—Headache—Etoposide—muscle cancer	0.000462	0.00256	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—muscle cancer	0.000462	0.00256	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—muscle cancer	0.000461	0.00255	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—muscle cancer	0.000461	0.00255	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—muscle cancer	0.000456	0.00252	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000449	0.000865	CbGpPWpGaD
Pentosan Polysulfate—Infection—Methotrexate—muscle cancer	0.000439	0.00243	CcSEcCtD
Pentosan Polysulfate—Nausea—Etoposide—muscle cancer	0.000438	0.00243	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—muscle cancer	0.000435	0.00241	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—muscle cancer	0.000433	0.0024	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—muscle cancer	0.000433	0.0024	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—muscle cancer	0.000431	0.00239	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—CD34—muscle cancer	0.00043	0.000829	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—MDM2—muscle cancer	0.000428	0.000825	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—muscle cancer	0.000427	0.00237	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—muscle cancer	0.000423	0.00234	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—muscle cancer	0.000421	0.00233	CcSEcCtD
Pentosan Polysulfate—FGF2—Developmental Biology—FOXO1—muscle cancer	0.00042	0.000809	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Doxorubicin—muscle cancer	0.00042	0.00233	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000409	0.000789	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—FOXO1—muscle cancer	0.000407	0.000784	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000403	0.00223	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—muscle cancer	0.0004	0.00221	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—muscle cancer	0.000399	0.00221	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—muscle cancer	0.000399	0.00221	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—muscle cancer	0.000397	0.0022	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—muscle cancer	0.000394	0.00219	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—muscle cancer	0.000394	0.00218	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—FOXO1—muscle cancer	0.000391	0.000753	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—MDM2—muscle cancer	0.00039	0.000752	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Methotrexate—muscle cancer	0.000389	0.00216	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—MDM2—muscle cancer	0.000384	0.000741	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Methotrexate—muscle cancer	0.000384	0.00213	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—muscle cancer	0.000383	0.00212	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—muscle cancer	0.00038	0.00211	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTCH1—muscle cancer	0.00038	0.000732	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—muscle cancer	0.000375	0.00208	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—FOXO1—muscle cancer	0.000373	0.000719	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—FOXO1—muscle cancer	0.000371	0.000715	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—muscle cancer	0.00037	0.00205	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—MDM2—muscle cancer	0.000369	0.000712	CbGpPWpGaD
Pentosan Polysulfate—Anorexia—Doxorubicin—muscle cancer	0.000365	0.00202	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—muscle cancer	0.000364	0.00202	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—ENO2—muscle cancer	0.000363	0.0007	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000361	0.002	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—FOXO1—muscle cancer	0.000356	0.000686	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Methotrexate—muscle cancer	0.000351	0.00195	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—muscle cancer	0.000349	0.00194	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000349	0.00193	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—muscle cancer	0.000346	0.00192	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—FOXO1—muscle cancer	0.000345	0.000664	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—muscle cancer	0.000344	0.0019	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—muscle cancer	0.000341	0.00189	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000339	0.000654	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—muscle cancer	0.000337	0.00187	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—muscle cancer	0.000333	0.00184	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—ENO2—muscle cancer	0.000331	0.000638	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HMGA1—muscle cancer	0.00033	0.000636	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Doxorubicin—muscle cancer	0.000327	0.00181	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—FOXO4—muscle cancer	0.000327	0.00063	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—muscle cancer	0.000326	0.0018	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—FOXO4—muscle cancer	0.000321	0.000618	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CNR1—muscle cancer	0.000321	0.000618	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—muscle cancer	0.000315	0.00175	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000313	0.00173	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—muscle cancer	0.000313	0.00173	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—KIT—muscle cancer	0.00031	0.000597	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000309	0.000596	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Doxorubicin—muscle cancer	0.000304	0.00168	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—muscle cancer	0.000303	0.00168	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—muscle cancer	0.000302	0.00168	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—HMGA1—muscle cancer	0.000301	0.00058	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KIT—muscle cancer	0.000298	0.000574	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FOXO4—muscle cancer	0.000296	0.000571	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FOXO4—muscle cancer	0.000292	0.000564	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Methotrexate—muscle cancer	0.000292	0.00162	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—KIT—muscle cancer	0.000284	0.000548	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KIT—muscle cancer	0.000283	0.000545	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—muscle cancer	0.000282	0.00156	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—muscle cancer	0.000281	0.00156	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—muscle cancer	0.000279	0.00154	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—muscle cancer	0.000278	0.00154	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—muscle cancer	0.000277	0.00153	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KIT—muscle cancer	0.000271	0.000523	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Doxorubicin—muscle cancer	0.000271	0.0015	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—FOXO4—muscle cancer	0.00027	0.000521	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Methotrexate—muscle cancer	0.000263	0.00145	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—KIT—muscle cancer	0.000263	0.000506	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF2—muscle cancer	0.000262	0.000505	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—muscle cancer	0.000262	0.00145	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—muscle cancer	0.000253	0.0014	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—MDM2—muscle cancer	0.000244	0.00047	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Doxorubicin—muscle cancer	0.000243	0.00135	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—muscle cancer	0.000241	0.00134	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—FOXO1—muscle cancer	0.000241	0.000465	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTCH1—muscle cancer	0.000241	0.000465	CbGpPWpGaD
Pentosan Polysulfate—Dermatitis—Doxorubicin—muscle cancer	0.000241	0.00134	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—muscle cancer	0.00024	0.00133	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—FOXO1—muscle cancer	0.000237	0.000457	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—MDM2—muscle cancer	0.000234	0.000452	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Doxorubicin—muscle cancer	0.000227	0.00126	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—MDM2—muscle cancer	0.000224	0.000432	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MDM2—muscle cancer	0.000223	0.000429	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTCH1—muscle cancer	0.00022	0.000424	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FOXO1—muscle cancer	0.000219	0.000422	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FOXO1—muscle cancer	0.000216	0.000416	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—MDM2—muscle cancer	0.000214	0.000412	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FOXO4—muscle cancer	0.000207	0.0004	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MDM2—muscle cancer	0.000207	0.000399	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CNR1—muscle cancer	0.000204	0.000392	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FOXO1—muscle cancer	0.000199	0.000384	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—muscle cancer	0.000199	0.000384	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—muscle cancer	0.000191	0.000369	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FOXO4—muscle cancer	0.000189	0.000364	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CNR1—muscle cancer	0.000186	0.000358	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KIT—muscle cancer	0.000184	0.000354	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KIT—muscle cancer	0.00018	0.000348	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KIT—muscle cancer	0.000167	0.000321	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF2—muscle cancer	0.000166	0.000321	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KIT—muscle cancer	0.000165	0.000317	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FOXO1—muscle cancer	0.000153	0.000295	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KIT—muscle cancer	0.000152	0.000293	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF2—muscle cancer	0.000152	0.000293	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MDM2—muscle cancer	0.000145	0.000279	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MDM2—muscle cancer	0.000142	0.000274	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FOXO1—muscle cancer	0.00014	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—muscle cancer	0.000131	0.000253	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—muscle cancer	0.00013	0.00025	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—muscle cancer	0.000127	0.000244	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—muscle cancer	0.00012	0.000231	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—muscle cancer	0.000117	0.000225	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—muscle cancer	0.000115	0.000222	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—muscle cancer	0.00011	0.000212	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—muscle cancer	0.000106	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—muscle cancer	9.19e-05	0.000177	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—muscle cancer	8.38e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—muscle cancer	8.31e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—muscle cancer	6.98e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—muscle cancer	6.36e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—muscle cancer	5.27e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—muscle cancer	4.81e-05	9.27e-05	CbGpPWpGaD
